Results 171 to 180 of about 90,761 (279)

A rare case of POEMS syndrome with unique endoscopic presentation. [PDF]

open access: yesAnn Hematol
Zhou JK   +6 more
europepmc   +1 more source

MELAS‐Like Mitochondrial Encephalopathy With Catatonia Associated With a Pathogenic MT‐ND3 (m.10158 T > C) Mutation: A Case Report and Literature Review

open access: yesProgress in Neurology and Psychiatry, Volume 30, Issue 2, May 2026.
Abstract Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke‐like episodes (MELAS) is a rare multisystem mitochondrial disorder primarily caused by mutations in mitochondrial DNA. While it typically presents with stroke‐like episodes, seizures, and lactic acidosis, recent evidence highlights a broader clinical spectrum, including ...
Faezeh Khorshidian   +3 more
wiley   +1 more source

Polyneuropathy.

open access: yesCanadian family physician Medecin de famille canadien, 2010
Polyneuropathy is characterized by simultaneous bilateral symmetrical involvement of peripheral nerves. Clinical features in fully-developed cases are paresthesias, irregular 'glove and stocking' cutaneous sensory loss, loss of deep sensations, weakness of distal muscles of extremities, and absent deep tendon reflexes.
openaire   +1 more source

Acute tetraparesis in a labrador retriever with suspected ectopic insulinoma and paraneoplastic polyneuropathy

open access: yesVeterinary Record Case Reports, Volume 14, Issue 2, May 2026.
Summary This case report describes a 10‐year‐old, male, neutered labrador retriever that was presented with acute non‐ambulatory tetraparesis, later diagnosed with an ectopic insulinoma and paraneoplastic polyneuropathy. Clinical evaluation revealed severe hypoglycaemia, generalised neuromuscular signs and electromyography findings were consistent with
Laryssa Straub   +3 more
wiley   +1 more source

A Case of Ganglionopathy Presenting with Hyperkinetic Movements. [PDF]

open access: yesTremor Other Hyperkinet Mov (N Y)
Gunawardena S, Shuaib U, Siddiqui J.
europepmc   +1 more source

Optimizing Oligonucleotide Therapeutics: A Model‐Informed Drug Development Perspective

open access: yesClinical and Translational Science, Volume 19, Issue 5, May 2026.
ABSTRACT Oligonucleotide therapies have emerged as a powerful therapeutic class, providing novel solutions for diverse diseases through antisense oligonucleotides (ASOs), small interfering RNAs (siRNAs), and aptamers that specifically target and modulate gene expression or protein function. However, oligonucleotide development faces distinct challenges,
Ye Yuan   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy